Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-14 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |